Published in J Clin Endocrinol Metab on February 03, 2010
Molecular genetics and diagnosis of thyroid cancer. Nat Rev Endocrinol (2011) 2.96
Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab (2011) 2.93
Progress in molecular-based management of differentiated thyroid cancer. Lancet (2013) 2.44
Thyroid nodules (≥4 cm): can ultrasound and cytology reliably exclude cancer? World J Surg (2014) 2.40
Targeted next-generation sequencing panel (ThyroSeq) for detection of mutations in thyroid cancer. J Clin Endocrinol Metab (2013) 2.34
American Thyroid Association Statement on Surgical Application of Molecular Profiling for Thyroid Nodules: Current Impact on Perioperative Decision Making. Thyroid (2015) 2.11
Genetic alterations in the phosphatidylinositol-3 kinase/Akt pathway in thyroid cancer. Thyroid (2010) 2.05
Cost impact of molecular testing for indeterminate thyroid nodule fine-needle aspiration biopsies. J Clin Endocrinol Metab (2012) 1.24
RAS mutations in thyroid FNA specimens are highly predictive of predominantly low-risk follicular-pattern cancers. J Clin Endocrinol Metab (2013) 1.22
MicroRNA expression array identifies novel diagnostic markers for conventional and oncocytic follicular thyroid carcinomas. J Clin Endocrinol Metab (2012) 1.11
The utility of BRAF testing in the management of papillary thyroid cancer. Oncologist (2010) 1.03
Molecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate Cytology. J Clin Endocrinol Metab (2015) 1.02
RAS mutations in thyroid cancer. Oncologist (2013) 1.00
RET/PTC Translocations and Clinico-Pathological Features in Human Papillary Thyroid Carcinoma. Front Endocrinol (Lausanne) (2012) 1.00
Prognostic biomarkers in thyroid cancer. Virchows Arch (2014) 0.95
Molecular approaches to thyroid cancer diagnosis. Endocr Relat Cancer (2014) 0.93
Summary statement: utility of molecular marker testing in thyroid cancer. Surgery (2010) 0.90
The variable phenotype and low-risk nature of RAS-positive thyroid nodules. BMC Med (2015) 0.89
An Ep-ICD based index is a marker of aggressiveness and poor prognosis in thyroid carcinoma. PLoS One (2012) 0.88
Relevance of BRAF(V600E) mutation testing versus RAS point mutations and RET/PTC rearrangements evaluation in the diagnosis of thyroid cancer. Thyroid (2014) 0.87
PAX8/PPARγ rearrangement in thyroid nodules predicts follicular-pattern carcinomas, in particular the encapsulated follicular variant of papillary carcinoma. Thyroid (2014) 0.86
Differential diagnosis of thyroid nodules using fine-needle aspiration cytology and oncogene mutation screening: are we ready? F1000 Med Rep (2010) 0.83
Thyroid nodules with repeat nondiagnostic cytologic results: the role of clinical and ultrasonographic findings. World J Surg (2015) 0.83
MicroRNA as a diagnostic tool in fine-needle aspiration biopsy of thyroid nodules. Oncologist (2012) 0.83
A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma. Nat Rev Endocrinol (2016) 0.83
Detection of PAX8/PPARG and RET/PTC rearrangements is feasible in routine air-dried fine needle aspiration smears. Thyroid (2012) 0.82
Diagnostic value of BRAF (V600E)-mutation analysis in fine-needle aspiration of thyroid nodules: a meta-analysis. Onco Targets Ther (2016) 0.82
Tumor genotype determines phenotype and disease-related outcomes in thyroid cancer: a study of 1510 patients. Ann Surg (2015) 0.81
Microrna-199a-5p Functions as a Tumor Suppressor via Suppressing Connective Tissue Growth Factor (CTGF) in Follicular Thyroid Carcinoma. Med Sci Monit (2016) 0.81
Employing genetic markers to improve diagnosis of thyroid tumor fine needle biopsy. Curr Genomics (2011) 0.80
Molecular diagnostics of fine needle aspiration for the presurgical screening of thyroid nodules. Curr Genomics (2014) 0.80
Clinical application of molecular testing of fine-needle aspiration specimens in thyroid nodules. Otolaryngol Clin North Am (2014) 0.80
Genetic Heterogeneity of HER2 Amplification and Telomere Shortening in Papillary Thyroid Carcinoma. Int J Mol Sci (2016) 0.80
Impact of molecular testing in the diagnosis of thyroid fine needle aspiration cytology: data from mainland China. Dis Markers (2014) 0.79
Molecular Signature of Indeterminate Thyroid Lesions: Current Methods to Improve Fine Needle Aspiration Cytology (FNAC) Diagnosis. Int J Mol Sci (2017) 0.78
Molecular differences between human thyroid follicular adenoma and carcinoma revealed by analysis of a murine model of thyroid cancer. Endocrinology (2013) 0.78
The surgical management of thyroid cancer. Rambam Maimonides Med J (2014) 0.78
Evaluation of PTEN, PI3K, MTOR, and KRAS expression and their clinical and prognostic relevance to differentiated thyroid carcinoma. Contemp Oncol (Pozn) (2014) 0.78
Cytopathologic diagnosis of fine needle aspiration biopsies of thyroid nodules. World J Clin Cases (2016) 0.77
Contribution of the BRAF oncogene in the pre-operative phase of thyroid carcinoma. Oncol Lett (2013) 0.77
Controversies in the management and followup of differentiated thyroid cancer: beyond the guidelines. J Thyroid Res (2012) 0.76
Thyroid function: optimizing molecular testing in thyroid nodule cytology. Nat Rev Endocrinol (2012) 0.75
Methylation Markers for Early Detection and Differentiation of Follicular Thyroid Cancer Subtypes. Cancer Clin Oncol (2015) 0.75
Molecular profiling of thyroid nodule fine-needle aspiration cytology. Nat Rev Endocrinol (2017) 0.75
Molecular Profiling of Thyroid Nodules: Current Role for the Afirma Gene Expression Classifier on Clinical Decision Making. Mol Imaging Radionucl Ther (2016) 0.75
Correlation Between Histological Diagnosis and Mutational Panel Testing of Thyroid Nodules: A Two-Year Institutional Experience. Thyroid (2016) 0.75
Thyroid carcinoma-associated genetic mutations also occur in thyroid lymphomas. Mod Pathol (2012) 0.75
Simultaneously Detection of 50 Mutations at 20 Sites in the BRAF and RAS Genes by Multiplexed Single-Nucleotide Primer Extension Assay Using Fine-Needle Aspirates of Thyroid Nodules. Yale J Biol Med (2015) 0.75
Well-differentiated thyroid carcinomas: management of the central lymph node compartment and emerging biochemical markers. J Oncol (2011) 0.75
Promise and pitfalls of molecular markers of thyroid nodules. Indian J Endocrinol Metab (2012) 0.75
Preoperative detection of RAS mutation may guide extent of thyroidectomy. Surgery (2016) 0.75
European Thyroid Association Guidelines regarding Thyroid Nodule Molecular Fine-Needle Aspiration Cytology Diagnostics. Eur Thyroid J (2017) 0.75
Thyroid nodule update on diagnosis and management. Clin Diabetes Endocrinol (2016) 0.75
A 2016 Italian Survey about Guidelines and Clinical Management of Thyroid Nodules. Eur Thyroid J (2016) 0.75
Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid (2009) 35.34
Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid (2009) 10.20
Phase II study of safety and efficacy of motesanib in patients with progressive or symptomatic, advanced or metastatic medullary thyroid cancer. J Clin Oncol (2009) 2.77
Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study. J Clin Endocrinol Metab (2007) 2.74
Post-surgical thyroid ablation with low or high radioiodine activities results in similar outcomes in intermediate risk differentiated thyroid cancer patients. Eur J Endocrinol (2013) 2.43
A gene network bioinformatics analysis for pemphigoid autoimmune blistering diseases. Clin Oral Investig (2014) 1.97
Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal. J Nucl Med (2006) 1.86
Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. J Clin Endocrinol Metab (2004) 1.82
BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas. J Clin Endocrinol Metab (2004) 1.79
Delayed risk stratification, to include the response to initial treatment (surgery and radioiodine ablation), has better outcome predictivity in differentiated thyroid cancer patients. Eur J Endocrinol (2011) 1.74
Minimally invasive video-assisted thyroidectomy for papillary carcinoma: a prospective study of its completeness. Surgery (2002) 1.71
Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question. J Clin Endocrinol Metab (2010) 1.63
Epidermal growth factor receptor 1 expression is upregulated in undifferentiated thyroid carcinomas in humans. Thyroid (2011) 1.58
Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Ann Intern Med (2003) 1.55
Low specificity of blood thyroglobulin messenger ribonucleic acid assay prevents its use in the follow-up of differentiated thyroid cancer patients. J Clin Endocrinol Metab (2004) 1.52
Expanding indications for recombinant human TSH in thyroid cancer. Thyroid (2008) 1.49
Initial experiences in radiology e-learning. Radiographics (2007) 1.45
A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal. J Clin Endocrinol Metab (2006) 1.45
Maternal pulse oximetry perfusion index as a predictor of early adverse respiratory neonatal outcome after elective cesarean delivery. Pediatr Crit Care Med (2008) 1.41
Ernest L. Mazzaferri, MD, MACP (1936-2013). Thyroid (2013) 1.39
Aneruptive fever associated with antibodies to Rickettsia helvetica in Europe and Thailand. J Clin Microbiol (2004) 1.37
Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective. Eur J Endocrinol (2004) 1.31
RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center. J Clin Endocrinol Metab (2007) 1.31
Regulation of monocyte chemoattractant protein-1 expression by tumor necrosis factor-alpha and interleukin-1beta in first trimester human decidual cells: implications for preeclampsia. Am J Pathol (2006) 1.27
Clinical features and therapeutic implication of papillary thyroid microcarcinoma. Thyroid (2007) 1.27
RET exon 11 (G691S) polymorphism is significantly more frequent in sporadic medullary thyroid carcinoma than in the general population. J Clin Endocrinol Metab (2004) 1.26
BRAFV600E mutation, but not RET/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer. Endocr Relat Cancer (2008) 1.26
A comparison of 1850 (50 mCi) and 3700 MBq (100 mCi) 131-iodine administered doses for recombinant thyrotropin-stimulated postoperative thyroid remnant ablation in differentiated thyroid cancer. J Clin Endocrinol Metab (2007) 1.23
Superselective ophthalmic artery infusion of melphalan for intraocular retinoblastoma: preliminary results from 140 treatments. Acta Ophthalmol (2012) 1.20
rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review. Endocr Relat Cancer (2005) 1.15
Short telomeres, telomerase reverse transcriptase gene amplification, and increased telomerase activity in the blood of familial papillary thyroid cancer patients. J Clin Endocrinol Metab (2008) 1.14
Uterine leiomyoma: available medical treatments and new possible therapeutic options. J Clin Endocrinol Metab (2013) 1.12
Mechanisms of abruption-induced premature rupture of the fetal membranes: thrombin-enhanced interleukin-8 expression in term decidua. Am J Pathol (2005) 1.09
Orbital solitary fibrous tumor with aggressive behaviorThree cases and review of the literature. Graefes Arch Clin Exp Ophthalmol (2002) 1.08
Potential utility and limitations of thyroid cancer cell lines as models for studying thyroid cancer. Thyroid (2009) 1.07
The immunoconjugate "icon" targets aberrantly expressed endothelial tissue factor causing regression of endometriosis. Am J Pathol (2009) 1.06
Lack of association between urinary iodine excretion and successful thyroid ablation in thyroid cancer patients. J Clin Endocrinol Metab (2009) 1.06
Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update. J Clin Endocrinol Metab (2013) 1.05
Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes. Eur J Endocrinol (2010) 1.04
Tumor necrosis factor-alpha and interleukin-1beta regulate interleukin-8 expression in third trimester decidual cells: implications for the genesis of chorioamnionitis. Am J Pathol (2006) 1.03
Follow-up and management of differentiated thyroid carcinoma: a European perspective in clinical practice. Eur J Endocrinol (2004) 1.02
The effects of recombinant TSH on bone turnover markers and serum osteoprotegerin and RANKL levels. Thyroid (2008) 1.01
Time evolution of nanoparticle-protein corona in human plasma: relevance for targeted drug delivery. Langmuir (2013) 1.00
L-thyroxine requirement in patients with autoimmune hypothyroidism and parietal cell antibodies. J Clin Endocrinol Metab (2007) 0.98
Activation of nicotinamide N-methyltransferase gene promoter by hepatocyte nuclear factor-1beta in human papillary thyroid cancer cells. Mol Endocrinol (2004) 0.97
Primary intradural Ewing's sarcoma of the cauda equina presenting with acute bleeding. Acta Neurochir (Wien) (2009) 0.97
Disease pathways in proliferative vitreoretinopathy: an ongoing challenge. J Cell Physiol (2014) 0.96
Telomeres and thyroid cancer. Curr Genomics (2009) 0.96
Amniotic membrane transplantation in ocular surface disorders. J Cell Physiol (2005) 0.95
Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma. Am J Pathol (2002) 0.95
Evaluation of posttreatment response of hepatocellular carcinoma: comparison of ultrasonography with second-generation ultrasound contrast agent and multidetector CT. Abdom Imaging (2009) 0.94
Thyroid autoantibodies and thyroid function in subjects exposed to Chernobyl fallout during childhood: evidence for a transient radiation-induced elevation of serum thyroid antibodies without an increase in thyroid autoimmune disease. J Clin Endocrinol Metab (2008) 0.94
Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity ¹³¹I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-up. J Clin Endocrinol Metab (2013) 0.94
A novel NKX2.1 mutation in a family with hypothyroidism and benign hereditary chorea. Thyroid (2008) 0.94
Serum ghrelin as a marker of atrophic body gastritis in patients with parietal cell antibodies. J Clin Endocrinol Metab (2007) 0.94
Implant survival in maxillary and mandibular osseous onlay grafts and native bone: a 3-year clinical and computerized tomographic follow-up. Int J Oral Maxillofac Implants (2009) 0.94
Histologic chorioamnionitis and severity of illness in very low birth weight newborns. Pediatr Crit Care Med (2005) 0.93
The RET/PTC oncogene is frequently activated in oncocytic thyroid tumors (Hurthle cell adenomas and carcinomas), but not in oncocytic hyperplastic lesions. J Clin Endocrinol Metab (2002) 0.93
Intra-amniotic infection upregulates neutrophil gelatinase-associated lipocalin (NGAL) expression at the maternal-fetal interface at term: implications for infection-related preterm birth. Reprod Sci (2011) 0.92
Circulating miRNA95 and miRNA190 are sensitive markers for the differential diagnosis of thyroid nodules in a Caucasian population. J Clin Endocrinol Metab (2014) 0.91
Intra-arterial chemotherapy with melphalan for intraocular retinoblastoma. Br J Ophthalmol (2013) 0.91
Expression pattern alterations of the serine protease HtrA1 in normal human placental tissues and in gestational trophoblastic diseases. Histol Histopathol (2009) 0.91
Treatment with drugs able to reduce iodine efflux significantly increases the intracellular retention time in thyroid cancer cells stably transfected with sodium iodide symporter complementary deoxyribonucleic acid. J Clin Endocrinol Metab (2006) 0.91
Volume changes of autogenous bone after sinus lifting and grafting procedures: a 6-year computerized tomographic follow-up. J Craniomaxillofac Surg (2012) 0.90
Nestin expression in adult and developing human kidney. J Histochem Cytochem (2007) 0.90
Epigenetic and copy number variation analysis in retinoblastoma by MS-MLPA. Pathol Oncol Res (2012) 0.90
Telomere length in neoplastic and nonneoplastic tissues of patients with familial and sporadic papillary thyroid cancer. J Clin Endocrinol Metab (2011) 0.90
The implication of aberrant GM-CSF expression in decidual cells in the pathogenesis of preeclampsia. Am J Pathol (2010) 0.90
Cytotoxic effects of carboplatinum and epirubicin in the setting of an elevated serum thyrotropin for advanced poorly differentiated thyroid cancer. J Clin Endocrinol Metab (2002) 0.90
Small thymus at birth: a predictive radiographic sign of bronchopulmonary dysplasia. Pediatrics (2002) 0.89
Perinatal outcome and placental histological characteristics: a single-center study. J Matern Fetal Neonatal Med (2012) 0.88
Telomere abnormalities and chromosome fragility in patients affected by familial papillary thyroid cancer. J Clin Endocrinol Metab (2012) 0.88
Knockdown of IG20 gene expression renders thyroid cancer cells susceptible to apoptosis. J Clin Endocrinol Metab (2009) 0.88
Genomic differences between retinoma and retinoblastoma. Acta Oncol (2008) 0.87
Histologic chorioamnionitis at term: implications for the progress of labor and neonatal wellbeing. J Matern Fetal Neonatal Med (2012) 0.87
Intra-amniotic infection upregulates decidual cell vascular endothelial growth factor (VEGF) and neuropilin-1 and -2 expression: implications for infection-related preterm birth. Reprod Sci (2009) 0.87
The role of survivin in thyroid tumors: differences of expression in well-differentiated, non-well-differentiated, and anaplastic thyroid cancers. Thyroid (2013) 0.87
All-trans-retinoic acid treatment inhibits the growth of retinoic acid receptor beta messenger ribonucleic acid expressing thyroid cancer cell lines but does not reinduce the expression of thyroid-specific genes. J Clin Endocrinol Metab (2004) 0.87
Changing natural history of differentiated thyroid cancer. Endocrine (2012) 0.86
Growth of congenital malignant teratoid medulloepithelioma of the ciliary body: a case study. J Neurooncol (2009) 0.86
Small thymus at birth and gestational age. Eur J Pediatr (2002) 0.86
Predictive value of skin color for illness severity in the high-risk newborn. Pediatr Res (2002) 0.86
Downregulation and aberrant promoter methylation of p16INK4A: a possible novel heritable susceptibility marker to retinoblastoma. J Cell Physiol (2010) 0.86
Thrombin regulates soluble fms-like tyrosine kinase-1 (sFlt-1) expression in first trimester decidua: implications for preeclampsia. Am J Pathol (2007) 0.86